Cargando…
Novel delivery methods to achieve immunomodulation
Immunomodulation in infectious diseases, cancer, cardiovascular disease and autoimmunity can now be targeted by sophisticated protein design, altering cellular responses by increasing therapeutic cell numbers ex vivo and then reimplanting, or altering cell function by gene transfer of cells ex vivo....
Autores principales: | Gould, David J, Chernajovsky, Yuti |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679984/ https://www.ncbi.nlm.nih.gov/pubmed/17611159 http://dx.doi.org/10.1016/j.coph.2007.05.002 |
Ejemplares similares
-
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-α inhibitor expressed from a self-contained doxycycline regulated plasmid
por: Gould, David J, et al.
Publicado: (2004) -
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005) -
Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis
por: Gould, David, et al.
Publicado: (2007) -
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
por: Subang, Maria C., et al.
Publicado: (2011) -
Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis
por: Rabinovich, Gabriel A., et al.
Publicado: (1999)